Short Article,  J Regen Med Vol: 12 Issue: 4

Spark Wave® Therapy-Assisted Treatment of Androgenic Alopecia: A Safe and Effective Alternative to Surgical Hair Transplant

Naz Elina^*

Kharkiv National Medical University, Ukraine, MedTheme Corporation, Bangladesh

*Corresponding Author: Naz Elina
Kharkiv National Medical University, Ukraine, MedTheme Corporation, Bangladesh
E-mail: niazmirza111@gmail.com

Received: 28-May-2023, Manuscript No. JRGM-23-100388
Editor assigned: 31-May-2023, PreQC No. JRGM-23-100388 (PQ)
Reviewed: 07-Jun-2023, QC No. JRGM-23-100388
Revised: 26-Jun-2023, Manuscript No. JRGM-23-100388 (R);
Published: 03-Jul-2023, DOI:10.4172/2325-9620.1000255

Citation: Elina N (2023) Spark Wave^® Therapy, Assisted Treatment of Androgenic Alopecia: A Safe and Effective Alternative to Surgical Hair Transplant. J Regen Med 12:4.

Copyright: © 2023 Elina N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Abstract

Keywords: Androgenic alopecia; Spark Wave® Therapy; Surgical hair transplant; Hair restoration; Microneedling; Dermaroller; Homeostasis; Repair mechanism; Angiogenesis; Regeneration; Efficacy; Clinical trials; Treatment protocol; Safety; Non-surgical alternative.

Introduction

Androgenic alopecia, a prevalent condition affecting both men and women, often leads to significant distress and a desire for hair restoration. While surgical hair transplant procedures have traditionally been the primary treatment option, recent advancements have introduced a novel therapeutic alternative known as Spark Wave^® Therapy (SWT)-assisted treatment [1]. This literature aims to explore the concept of SWT-assisted treatment for androgenic alopecia [2-5], its methodology, limitations, and implications, and provide a comprehensive conclusion.

Materials and Methods

The methodology behind SWT-assisted treatment involves the utilization of a dermaroller embedded with microneedles of medicalgrade, typically ranging from 0.5 to 3 mm in length. When applied to the scalp, the dermaroller creates controlled microdamages in the epidermis and dermis layers, triggering the body’s innate repair mechanism [6]. This activation promotes an increase in hair follicle count and stimulates the growth of existing hair.

In combination with microneedling (Figure 1), SWT is employed to further enhance the therapeutic effects [7]. SWT induces angiogenesis and regeneration, ensuring an adequate blood supply to the scalp. Sufficient blood flow is crucial for the maintenance, repair, and growth of new hair follicles. The integration of SWT into the treatment protocol aims to accelerate and intensify hair growth, surpassing the limitations imposed by the body’s natural repair mechanism.

Limitations

Despite the potential benefits of SWT-assisted treatment for androgenic alopecia [8], several limitations must be considered. Firstly, as a relatively new therapeutic approach, the efficacy and longterm outcomes of this treatment require comprehensive evaluation through clinical trials. Robust scientific studies with large sample sizes and extended follow-up periods are essential to establish its effectiveness, safety, and durability.

Moreover, the optimal treatment protocol, including the frequency and duration of sessions, has not been standardized. Variability in treatment parameters [9] across different studies necessitates further research to determine the most effective approach for SWT-assisted treatment. Additionally, individual responses to the therapy may vary, making personalized treatment plans crucial for achieving optimal results.

Discussion

The combination therapy of microneedling and SWT holds significant promise as a safe and effective alternative to surgical hair transplants [10,11]. This office-based procedure offers several advantages, including its minimally invasive nature, cost-effectiveness, and minimal risk of unintended side effects. By leveraging the body’s natural healing mechanisms and promoting angiogenesis and regeneration, SWT-assisted treatment presents a novel approach to address androgenic alopecia.

Clinical trials evaluating SWT-assisted treatment are necessary to provide robust evidence and guide clinical practice [12, 13]. Through rigorous research, the efficacy and safety of this therapy can be established, allowing healthcare practitioners to confidently incorporate it into their treatment options. Additionally, further investigations are warranted to determine the optimal treatment parameters, refine the technique, and identify potential patient selection criteria that would benefit most from this approach.

Conclusion

Spark Wave^® Therapy-assisted treatment of androgenic alopecia represents a promising alternative to surgical hair transplants. By combining microneedling with SWT, this therapeutic approach capitalizes on the body’s innate repair mechanisms and promotes accelerated and intensified hair growth. While limitations exist, including the need for further clinical trials and standardization of treatment protocols, the potential benefits make SWT-assisted treatment an appealing option for individuals seeking hair restoration. Through on-going research and validation, SWT-assisted treatment has the potential to revolutionize the field of hair restoration, providing patients with a safe, effective, and non-surgical solution for androgenic alopecia.

References

1. Luebberding S, Krueger N, Sadick NS (2015) Cellulite: An Evidence-Based Review. Am J Clin Dermatol, 16(4):243-256.

Indexed at, Google Scholar, Cross Ref

2. Mustoe TA, Cooter RD, Gold MH, Hobbs FDR, Ramelet AA, et al. (2002) PTSD is a chronic, fluctuating disorder affecting the mental quality of life in older adults. Plast Reconstr Surg, 110(2):560-71.

Indexed at, Google Scholar

3. Saggini R, Saggini A, Spagnoli AM, Dodaj I, Cigna E, et al. (2015) Etracorporeal Shock Wave Therapy: An Emerging Treatment Modality for Retracting Scars of the Hands. Ultrasound Med Biol, 42(1):185-195.

Indexed at, Google Scholar,Cross Ref

4. Widgerow AD (2011) Cellular/Extracellular Matrix Cross-Talk in Scar Evolution and Control. Wound Repair Regen, 19(2):117-33.

Indexed at, Google Scholar, Cross Ref

5. Zhang L, et al. (2018) Efficacy and Safety of Extracorporeal Shock Wave Therapy for Acute and Chronic Soft Tissue Wounds: A Systematic Review and Meta-Analysis. Int Wound J, 15(4):590-599.

Indexed at, Google Scholar, Cross Ref

6. Zhang L, et al. (2018) Lower Energy Radial Shock Wave Therapy Improves Characteristics of Hypertrophic Scar in a Rabbit Ear Model. Exp Ther Med, 15(1):933-939.

Indexed at, Google Scholar, Cross Ref

7. Cui HS, Hong AR, Kim JB, Yu JH, Cho YS, et al. (2018) Extracorporeal Shock Wave Therapy Alters the Expression of Fibrosis-Related Molecules in Fibroblast Derived from Human Hypertrophic Scar. Int J Mol Sci, 19(1):124.

Indexed at, Google Scholar, Cross Ref

8. Zhao JC, Zhang BR, Hong L, Shi K, Wu WW, et al. (2018) Extracorporeal Shock Wave Therapy with Low-Energy Flux Density Inhibits Hypertrophic Scar Formation in an Animal Model. Int J Mol Med, 41(4):1931-1938.

Indexed at, Google Scholar, Cross Ref

9. Taheri P, Khosrawi S, Mazaheri M, Parsa MA, Mokhtarian A (2018) Effect of Extracorporeal Shock Wave Therapy on Improving Burn Scar in Patients with Burnt Extremities in Isfahan, Iran. J Res Med Sci, 23:81.
10. Cho YS, Joo SY, Cui H, Cho SR, Yim H, et al. (2016) Effect of Extracorporeal Shock Wave Therapy on Scar Pain in Burn Patients: A Prospective, Randomized, Single-Blind, Placebo-Controlled Study. Medicine (Baltimore), 95(32):e4575.

Indexed at, Google Scholar, Cross Ref

11. Fioramonti P, Cigna E, Onesti MG, Fino P, Fallico N, et al. (2012) Extracorporeal Shock Wave Therapy for the Management of Burn Scars. Dermatologic Surg, 38(5):778-782.

Indexed at, Google Scholar, Cross Ref

12. Wang CJ, Ko JY, Chou WY, Cheng JH, Kuo YR (2018) Extracorporeal Shockwave Therapy for Treatment of Keloid Scars. Wound Repair Regen, 26(1):69-76.

Indexed at, Google Scholar, Cross Ref

13. Ottomann C, Stojadinovic A, Lavin PT, Gannon FH, Heggeness MH, et al. (2012) Prospective Randomized Phase II Trial of Accelerated Reepithelialization of Superficial Second-Degree Burn Wounds Using Extracorporeal Shock Wave Therapy. Ann Surg, 255(1):23-29.

Indexed at, Google Scholar